Benefits of omalizumab as add-on therapy in patients with severe persistent asthma who are inadequately controlled despite best available therapy (GINA 2002 step 4 treatment): INNOVATE - Humbert, M; Beasley, R; Ayres, J (Allergy, 2005)
et al.